Godavari Drugs Ltd

Godavari Drugs Ltd (530317)


Key Stats

Day's Price Range
52-Week Price Range
1 Month Return-5.63 %
3 Month Return6.33 %
1 Year Return-2.62 %

Company Financials

  • Annual
Value in ₹ crore

Peer Comparsion

Rank 299
Rank 303
Rank 326
Dividend Yield
Rank 177
Rank 110
Price To Book Ratio
Rank 262
Debt To Asset
Rank 316

Company Information

Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole SMX the main product of the company is a widely used antibacterial drug enjoying good export demand.The company has expanded its SMX capacity from 540 tpa to 720 tpa integrating backward into the manufacture of drug intermediates sulphamethoxide cap.: 450 tpa and diethyl oxalate DEO cap.: 750 tpa and diversifying into the manufacture of trimetroprim TMP cap.: 144 tpa.The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance valueaddition. In fact Siris and Chemox Chemicals both having good capacities of SMX have recently gone in for the production of SMO. In 2000 the company introduced Pyrazyamide in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of Pyrazyamide of 180 TPA and have also finalised on other products Cislactumwhich is a intermediate used to produce Diltiazem an anti anginal drug.
OrganisationGodavari Drugs Ltd